← Back to Search

MRI-guided prostate biopsy for Prostate Cancer

N/A

Recruiting

Led By Kemal Tuncali, MD

Research Sponsored by Brigham and Women's Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during the mri-guided prostate biopsy procedure

Awards & highlights

Study Summary

This trial will test if using a special device called a needle holder frame during a prostate biopsy guided by magnetic resonance imaging (MRI) is feasible. Feasibility here means that the frame can help accurately

Who is the study for?

This trial is for men over 30 with suspected prostate cancer, who have either an abnormal PSA level (>4ng/Ml), a palpable nodule on examination, or a suspicious lesion seen in prostate MRI. They must be able to consent and have no contraindications to MRI like pacemakers, inner ear implants, or certain brain aneurysm clips.Check my eligibility

What is being tested?

The study tests the feasibility of using a needle holder frame for MR-guided prostate biopsies. It aims to see if this new tool can accurately sample tissue from areas of concern identified by MRI during routine biopsy procedures.See study design

What are the potential side effects?

While not explicitly listed, potential side effects may include discomfort at the biopsy site, bleeding, infection risk post-procedure and possible reactions related to lying still inside the MRI machine.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during the mri-guided prostate biopsy procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during the mri-guided prostate biopsy procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and during the mri-guided prostate biopsy procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Accuracy of needle placement

Trial Design

1Treatment groups

Experimental Treatment

Group I: MRI-guided prostate biopsyExperimental Treatment1 Intervention

Participants who receive biopsy under MRI-guidance and a needle holder frame.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor

1,616 Previous Clinical Trials

11,470,935 Total Patients Enrolled

22 Trials studying Prostate Cancer

32,772 Patients Enrolled for Prostate Cancer

National Cancer Institute (NCI)NIH

13,670 Previous Clinical Trials

40,926,721 Total Patients Enrolled

561 Trials studying Prostate Cancer

507,095 Patients Enrolled for Prostate Cancer

Physical Sciences Inc.UNKNOWN

1 Previous Clinical Trials

38 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants currently being sought for enrollment in this medical study?

"As per clinicaltrials.gov, this research investigation is currently in the process of seeking suitable participants. The trial's initial posting was on August 24th, 2023, with the latest update made on March 8th, 2024."

Answered by AI

What is the total number of participants being recruited for this clinical investigation?

"Yes, as per the details on clinicaltrials.gov, this investigation is actively enrolling subjects. The trial was initially listed on August 24th, 2023 and most recently revised on March 8th, 2024. Recruitment aims to enlist a total of 15 participants at one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MRI Guided Prostate Biopsy

Kemal Tuncali, M.D. 2023. "MRI Guided Prostate Biopsy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06302595.

All > Paid Studies Boston